Brief Report: Effects of Low-Volume High-Intensity Interval Training in Hispanic HIV+ Women: A Nonrandomized Study.


Journal

Journal of acquired immune deficiency syndromes (1999)
ISSN: 1944-7884
Titre abrégé: J Acquir Immune Defic Syndr
Pays: United States
ID NLM: 100892005

Informations de publication

Date de publication:
01 07 2020
Historique:
entrez: 13 6 2020
pubmed: 13 6 2020
medline: 5 1 2021
Statut: ppublish

Résumé

Low cardiorespiratory fitness (CRF) is usually observed in people living with HIV. The effect of a low-volume high-intensity interval training (LV-HIIT) on CRF in HIV+ and HIV- Hispanic women was evaluated in this study. A nonrandomized clinical trial with pre-test and post-test using a LV-HIIT intervention was conducted in the AIDS Clinical Trials Unit and the Puerto Rico Clinical and Translational Research Consortium at the University of Puerto Rico Medical Sciences Campus. Twenty-nine HIV+ and 13 HIV- Hispanic women recruited from community-based programs and clinics, and able to engage in daily physical activities, volunteered to participate. Of these, 20 HIV+ (69%) and 11 HIV- (85%) completed the study and were included in the analyses. LV-HIIT consisted of 6-week, 3 d/wk, 8-10 high-intensity and low-intensity intervals on a cycle ergometer at 80%-90% of heart rate reserve. Main outcome measures were CRF (defined as VO2peak), peak workload, and time to peak exercise. Average peak workload and time to peak exercise increased after training (P < 0.05) in both groups. However, average CRF was significantly higher after training only in the HIV- group. Gains in CRF were observed in 100% of HIV- and 50% of HIV+ women. This was not influenced by exercise testing, habitual physical activity, or anthropometric variables. Given the lack of change in CRF observed in the HIV+ group after LV-HIIT intervention, it is important to focus on variations that may occur within groups.

Sections du résumé

BACKGROUND
Low cardiorespiratory fitness (CRF) is usually observed in people living with HIV. The effect of a low-volume high-intensity interval training (LV-HIIT) on CRF in HIV+ and HIV- Hispanic women was evaluated in this study.
SETTING
A nonrandomized clinical trial with pre-test and post-test using a LV-HIIT intervention was conducted in the AIDS Clinical Trials Unit and the Puerto Rico Clinical and Translational Research Consortium at the University of Puerto Rico Medical Sciences Campus.
METHODS
Twenty-nine HIV+ and 13 HIV- Hispanic women recruited from community-based programs and clinics, and able to engage in daily physical activities, volunteered to participate. Of these, 20 HIV+ (69%) and 11 HIV- (85%) completed the study and were included in the analyses. LV-HIIT consisted of 6-week, 3 d/wk, 8-10 high-intensity and low-intensity intervals on a cycle ergometer at 80%-90% of heart rate reserve. Main outcome measures were CRF (defined as VO2peak), peak workload, and time to peak exercise.
RESULTS
Average peak workload and time to peak exercise increased after training (P < 0.05) in both groups. However, average CRF was significantly higher after training only in the HIV- group. Gains in CRF were observed in 100% of HIV- and 50% of HIV+ women. This was not influenced by exercise testing, habitual physical activity, or anthropometric variables.
CONCLUSIONS
Given the lack of change in CRF observed in the HIV+ group after LV-HIIT intervention, it is important to focus on variations that may occur within groups.

Identifiants

pubmed: 32530906
doi: 10.1097/QAI.0000000000002353
pii: 00126334-202007010-00007
pmc: PMC8384056
mid: NIHMS1578089
doi:

Banques de données

ClinicalTrials.gov
['NCT02962622']

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

285-289

Subventions

Organisme : NIMHD NIH HHS
ID : R25 MD007607
Pays : United States
Organisme : NIMHD NIH HHS
ID : U54 MD007587
Pays : United States
Organisme : NIMH NIH HHS
ID : R21 MH095524
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI069415
Pays : United States
Organisme : NIMHD NIH HHS
ID : S21 MD001830
Pays : United States

Références

J Am Heart Assoc. 2014 Oct 16;3(5):e001035
pubmed: 25324353
Clin Infect Dis. 2016 Oct 15;63(8):1122-1129
pubmed: 27444412
BMC Infect Dis. 2016 Apr 26;16:182
pubmed: 27112335
J Sports Sci Med. 2019 Feb 11;18(1):181-190
pubmed: 30787666
Braz J Infect Dis. 2016 Jan-Feb;20(1):76-80
pubmed: 26707972
J Appl Physiol (1985). 2011 Dec;111(6):1554-60
pubmed: 21868679
J Cardiovasc Nurs. 2019 Sep/Oct;34(5):364-371
pubmed: 31343620
PLoS One. 2013 Sep 16;8(9):e73182
pubmed: 24066036
Prog Cardiovasc Dis. 2017 Jun - Jul;60(1):11-20
pubmed: 28286137
J Appl Physiol (1985). 2001 May;90(5):1770-6
pubmed: 11299267
J Physiol. 2012 Mar 1;590(5):1077-84
pubmed: 22289907
Clin Infect Dis. 2018 Jun 1;66(12):1918-1927
pubmed: 29293942
Exerc Sport Sci Rev. 2018 Jul;46(3):138-143
pubmed: 29912036
Mayo Clin Proc. 2019 Aug;94(8):1406-1414
pubmed: 31303425
Am Heart J. 2018 Aug;202:116-126
pubmed: 29933148
AIDS Res Hum Retroviruses. 2006 Nov;22(11):1113-21
pubmed: 17147498
Prog Cardiovasc Dis. 2019 Mar - Apr;62(2):140-146
pubmed: 30685470
J Appl Physiol (1985). 2011 May;110(5):1160-70
pubmed: 21183627
Environ Mol Mutagen. 2007 Apr-May;48(3-4):166-72
pubmed: 16758472
AIDS Patient Care STDS. 2011 Jan;25(1):13-20
pubmed: 21214375
PLoS One. 2014 Nov 26;9(11):e113884
pubmed: 25426954
Am J Physiol Endocrinol Metab. 2007 Jun;292(6):E1666-73
pubmed: 17284576
BMJ Open. 2018 Sep 24;8(9):e022516
pubmed: 30249631
AIDS. 2019 May 1;33(6):1023-1030
pubmed: 30946156
Med Sci Sports Exerc. 2013 Aug;45(8):1436-42
pubmed: 23470301
J Assoc Nurses AIDS Care. 2019 Mar-Apr;30(2):186-205
pubmed: 30822291
J Am Geriatr Soc. 2005 Mar;53(3):528-35
pubmed: 15743301
J Acquir Immune Defic Syndr. 2018 Dec 1;79(4):491-500
pubmed: 30371532
P R Health Sci J. 2014 Dec;33(4):163-9
pubmed: 25563033
JAMA. 2009 May 20;301(19):2024-35
pubmed: 19454641
Clinics (Sao Paulo). 2013;68(8):1157-67
pubmed: 24037014
PLoS One. 2018 Jun 12;13(6):e0198855
pubmed: 29894513
Med Sci Sports Exerc. 1993 Jun;25(6):684-8
pubmed: 8100607
Med Sci Sports Exerc. 2019 Apr;51(4):681-691
pubmed: 30673687

Auteurs

Farah A Ramírez-Marrero (FA)

Rio Piedras Campus, University of Puerto Rico, San Juan, PR; and.

Sigrid Pérez-Frontera (S)

School of Medicine, University of Puerto Rico, San Juan, PR.

Marcos A Amalbert-Birriel (MA)

Rio Piedras Campus, University of Puerto Rico, San Juan, PR; and.

Miriam Matos (M)

School of Medicine, University of Puerto Rico, San Juan, PR.

Jorge Santana-Bagur (J)

School of Medicine, University of Puerto Rico, San Juan, PR.

Walter R Frontera (WR)

School of Medicine, University of Puerto Rico, San Juan, PR.

Valerie Wojna (V)

School of Medicine, University of Puerto Rico, San Juan, PR.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH